QT
EPZM

Quantbot Technologies’s Epizyme, Inc EPZM Stock Holding History

Quantbot Technologies’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-44,877
Closed -$112K – 2200
2021
Q4 		$112K Buy
+44,877
New +$176K 0.01% 845
2020
Q2 		– Sell
-137
Closed -$2K – 1532
2020
Q1 		$2K Sell
137
-4,231
-97% -$90.9K ﹤0.01% 822
2019
Q4 		$107K Sell
4,368
-1,034
-19% -$15.3K 0.01% 810
2019
Q3 		$55K Buy
+5,402
New +$68.1K 0.01% 949
2018
Q4 		– Sell
-8,894
Closed -$94K – 1540
2018
Q3 		$94K Buy
8,894
+922
+12% +$10.5K 0.01% 894
2018
Q2 		$108K Buy
7,972
+1,718
+27% +$26.7K 0.01% 860
2018
Q1 		$111K Buy
+6,254
New +$106K 0.01% 820
2017
Q4 		– Sell
-1,073
Closed -$20K – 1563
2017
Q3 		$20K Buy
+1,073
New +$16.4K ﹤0.01% 1058
2015
Q4 		– Sell
-10,648
Closed -$136K – 1467
2015
Q3 		$136K Buy
+10,648
New +$215K 0.02% 649
2015
Q2 		– Sell
-100
Closed -$1K – 1435
2015
Q1 		$1K Buy
+100
New +$2.06K ﹤0.01% 1017

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Quantbot Technologies's EPZM Position: Q1 2022 in Review

Quantbot Technologies sold out of Epizyme, Inc (EPZM) in Q1 2022, closing a stake of 44,877 shares — an estimated $112K sold.

Quantbot Technologies first reported a position in EPZM in Q1 2015 and held it in 10 quarters. The position peaked at $136K in Q3 2015. 120 funds tracked by Wall St. Rank hold EPZM as of Q1 2022.

  • Quantbot Technologies reported no remaining Epizyme, Inc position as of Q1 2022 after selling out during the quarter.
  • Quantbot Technologies sold 44,877 Epizyme, Inc shares in Q1 2022, an estimated $112K.
  • Quantbot Technologies first reported a position in Epizyme, Inc in Q1 2015 and held it in 10 quarters.
  • Quantbot Technologies's Epizyme, Inc position peaked at $136K in Q3 2015.
  • 120 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2022.

Based on Quantbot Technologies's 13F filing for Q1 2022, filed 16 May 2022.